221 related articles for article (PubMed ID: 1120982)
1. Synthesis and biological evaluation of xanthine oxidase inhibitors. Pyrazolo(3,4-d)pyrimidines and pyrazolo(3,4-b)pyridines.
Chu I; Lynch BM
J Med Chem; 1975 Feb; 18(2):161-5. PubMed ID: 1120982
[TBL] [Abstract][Full Text] [Related]
2. The synthesis and xanthine oxidase inhibitory activity of pyrazolo(3,4-d)pyrimidines.
Kobayashi S
Chem Pharm Bull (Tokyo); 1973 May; 21(5):941-51. PubMed ID: 4727362
[No Abstract] [Full Text] [Related]
3. Biochemical characterization of some pyrazolopyrimidine-based inhibitors of xanthine oxidase.
Tamta H; Kalra S; Mukhopadhyay AK
Biochemistry (Mosc); 2006; 71 Suppl 1():S49-54. PubMed ID: 16487068
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of N-aryl-5-amino-4-cyanopyrazole derivatives as potent xanthine oxidase inhibitors.
Gupta S; Rodrigues LM; Esteves AP; Oliveira-Campos AM; Nascimento MS; Nazareth N; Cidade H; Neves MP; Fernandes E; Pinto M; Cerqueira NM; Brás N
Eur J Med Chem; 2008 Apr; 43(4):771-80. PubMed ID: 17692432
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines.
Springer RH; Dimmitt MK; Novinson T; O'Brien DE; Robins RK; Simon LN; Miller JP
J Med Chem; 1976 Feb; 19(2):291-6. PubMed ID: 2778
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
[TBL] [Abstract][Full Text] [Related]
7. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
Abdel-Aziz HA; Saleh TS; El-Zahabi HS
Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
[TBL] [Abstract][Full Text] [Related]
8. 3-Hydroxy-1-nitrophenyl-1(H-pyrazolo(3,4-b)pyridines as selective inhibitors of rat liver xanthine oxidase.
Parmar SS; Pandey BR; Dwivedi C; Ali B
J Med Chem; 1974 Sep; 17(9):1031-3. PubMed ID: 4416932
[No Abstract] [Full Text] [Related]
9. Cancerostatica. I. synthesis of some pyrazolo[1,5-a]pyrimidine and pyrazolo [3,4-b] pyridine derivatives.
Nantka-Namirski P; Kaczmarek L
Pol J Pharmacol Pharm; 1978; 30(4):563-8. PubMed ID: 740557
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of pyrazolo[3,4-b]pyridine-3-yl pyrimidine derivatives as sGC stimulators for the treatment of pulmonary hypertension.
Li L; Zhang W; Lin F; Lu X; Chen W; Li X; Zhou X; Su R; Wang L; Zheng Z; Li S
Eur J Med Chem; 2019 Jul; 173():107-116. PubMed ID: 30995566
[TBL] [Abstract][Full Text] [Related]
15.
Malik N; Dhiman P; Khatkar A
Curr Drug Targets; 2019; 20(5):593-603. PubMed ID: 30465499
[TBL] [Abstract][Full Text] [Related]
16. Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.
Zhao J; Mao Q; Lin F; Zhang B; Sun M; Zhang T; Wang S
Eur J Med Chem; 2022 Feb; 229():114086. PubMed ID: 34992040
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyakalone, a novel xanthine oxidase inhibitor produced by a marine bacterium, Agrobacterium aurantiacum.
Izumida H; Adachi K; Mihara A; Yasuzawa T; Sano H
J Antibiot (Tokyo); 1997 Nov; 50(11):916-8. PubMed ID: 9592563
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of AutoDock and PMF scoring performances, and SAR of 2-substituted pyrazolotriazolopyrimidines and 4-substituted pyrazolopyrimidines as potent xanthine oxidase inhibitors.
Ali HI; Fujita T; Akaho E; Nagamatsu T
J Comput Aided Mol Des; 2010 Jan; 24(1):57-75. PubMed ID: 20039101
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and xanthine oxidase inhibitory activity of 5,6-dihydropyrazolo/pyrazolo[1,5-c]quinazoline derivatives.
Kumar D; Kaur G; Negi A; Kumar S; Singh S; Kumar R
Bioorg Chem; 2014 Dec; 57():57-64. PubMed ID: 25222504
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 3-(pyridin-6-yl)pyrazolo[1,5-a]pyrimidines.
Ibrahim NS; Mohamed MH; Elnagdi MH
Arch Pharm (Weinheim); 1987 Jun; 320(6):487-91. PubMed ID: 3662773
[No Abstract] [Full Text] [Related]
[Next] [New Search]
